PharmAlliance Announces Acquisition of CHEORS to strengthen global reach and expand capabilities
Acquiring Company
PharmAlliance
Acquired Company
CHEORS
MorrisvilleBiotechnologyHealth CareConsultingBiotechnologyHealth CareDescription
PharmAlliance, a diversified pharmaceutical and life sciences services platform, has announced the acquisition of Complete Health Economics Outcomes Research Solutions (CHEORS). With this strategic addition, PharmAlliance strengthens its global reach and expands its launch and commercialization capabilities, reinforcing its commitment to providing end-to-end solutions across the drug and device development lifecycle.
Quick answer
PharmAlliance is acquiring CHEORS, announced April 16, 2024. PharmAlliance is based in Morrisville, North Carolina, United States.
- How much did PharmAlliance pay for CHEORS?
- The deal value was not disclosed.
- What does PharmAlliance do?
- PharmAlliance is a diversified pharmaceutical and life sciences services platform designed to serve a variety of discovery, development, and commercialization needs across the drug and device development lifecycle..
- Where are PharmAlliance and CHEORS based?
- PharmAlliance is based in Morrisville, North Carolina, United States.
Source: Fundz verified event record.
Other recent acquisitions in Consulting and Biotechnology
Deals where the buyer or target shares a sector with this one, within 45 days, from Fundz verified event records.
- Novo Holdings A/S to acquire Catalent, Inc. for $63.50 per share in cash (May 29, 2024)
- AbbVie finalizes acquisition of Landos Biopharma, Inc. to advance treatment for ulcerative colitis and Crohn's disease (May 23, 2024)
- LCI completes acquisition of certain assets of Pfizer Pakistan Limited and Pfizer Inc. to enhance pharmaceutical portfolio (May 20, 2024)
- Zinzino acquires assets in Xelliss - strategic reinforcement in southern Europe and in the microalgae spirulina (May 12, 2024)
- Integrated Oncology Network completes acquisition of Urology Partners, LLC to expand urologic healthcare services (May 2, 2024)
- Ephicacy Consulting Group completes acquisition of Advance Research Associates to enhance biostatistics and data management capabilities (May 2, 2024)
Who to call at PharmAlliance, and when
When PharmAlliance changes hands, the new owners review vendors, systems and leadership. That is when the door opens.
- An alert the day PharmAlliance raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at PharmAlliance, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at PharmAlliance. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment PharmAlliance makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Frequently asked
Who acquired CHEORS?
CHEORS was acquired by PharmAlliance, based in Morrisville. The deal was reported on April 16, 2024. PharmAlliance is privately held and operates in Biotechnology.
When did PharmAlliance acquire CHEORS?
PharmAlliance's acquisition of CHEORS was reported on April 16, 2024. PharmAlliance, a diversified pharmaceutical and life sciences services platform, has announced the acquisition of Complete Health Economics Outcomes Research Solutions (CHEORS). Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does CHEORS do?
Complete Health Economics Outcomes Research Solutions (CHEORS) is a leading provider of global HEOR and market access services for the pharmaceutical, biotech, and medical device industry. It is privately held, operating in Biotechnology.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.